BMO Capital reiterates Morningstar stock rating citing AI strategy By Investing.com

BMO Capital reiterated an Outperform rating and $212 price target on Morningstar, but the stock has still fallen 42.5% over the past year to $175.84, well below its $316.71 52-week high. Management is addressing AI-related investor concerns through efficiencies, partnerships, contract changes, and share repurchases, while decelerating organic growth in PitchBook and Morningstar Direct remains a headwind. Recent corporate actions include a 50-cent quarterly dividend, the CRSP index rebrand, and the planned sale of ByAllAccounts.

Analysis

The key second-order effect is not the headline AI narrative itself, but the widening valuation gap between companies with real data/benchmarking distribution and those whose AI message is still mostly defensive. MORN is being punished because investors now require visible monetization from AI investments within a few quarters, not vague efficiency claims; that creates a higher bar for every “AI-enabled” information-services name. By contrast, STEP’s positive read-through is subtle: if benchmark and deal-data workflows become more embedded in customer systems, the switching costs rise, and the market may start assigning more platform-like multiples to niche data products rather than treating them as cyclical subscriptions.

For MORN, the risk is a slow-burn multiple compression rather than a near-term earnings collapse. If organic growth in the core data franchises stays in the low single digits for another 2-3 quarters, buybacks and dividends will only soften the downside, not change the narrative; the stock likely needs an unmistakable acceleration in product adoption or a meaningful acquisition to reset sentiment. The upside catalyst is a measurable inflection in paid AI features, contract structure changes that improve retention, or evidence that share repurchases are finally outpacing dilution and offsetting growth skepticism.

The broader winner from this setup may be vendors that monetize AI infrastructure inside enterprise workflows without carrying the burden of proving “AI growth” to public markets. That favors companies where AI is an embedded enhancement to a sticky product, not a standalone story. The contrarian point is that the market may be over-penalizing MORN for a narrative problem that can be solved with execution over 6-12 months, especially if capital returns remain aggressive and management uses the weakness to consolidate its product ecosystem.

Key Decisions for Investors

• Short MORN vs long STEP as a 3-6 month relative-value pair: the market is pricing MORN as an AI skeptic while STEP has a cleaner path to re-rating from data/benchmark integration; target 10-15% relative spread with a stop if MORN shows two consecutive quarters of organic growth inflection.
• For event-driven accounts, sell downside via MORN put spreads 2-4 months out: the thesis is gradual multiple compression, not a crash, so premium should remain supported while limiting upside risk if management surprises with AI monetization proof.
• Add STEP on weakness over 1-2 quarters: treat it as a compounding data-network name where incremental product partnerships can expand ARPU and defend retention; reward is a multiple expansion if investors begin valuing distribution and workflow embeddedness over headline growth alone.
• Avoid chasing MORN until there is evidence of AI revenue conversion or a clear turnaround in PitchBook/Morningstar Direct growth; the risk/reward is asymmetric against longs because buybacks cannot sustainably offset a narrative-driven de-rating.